NDAINTRAVENOUSINJECTABLE
Approved
Aug 2005
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
2/8 — Basic
FLUDEOXYGLUCOSE F18 (fludeoxyglucose f18) by Medica Corp is radiopharmaceutical activity [moa]. First approved in 2005.
Drug data last refreshed 4h ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Fludeoxyglucose F18 is a radioactive diagnostic agent administered intravenously for positron emission tomography (PET) imaging. It accumulates in tissues with elevated glucose metabolism, enabling detection of tumors, cardiac viability, and neurological conditions. This radiopharmaceutical works through glucose analog uptake in metabolically active cells.
LOE Approaching
As LOE approaches, commercial teams face contraction; focus shifts toward operational efficiency and competitive differentiation in the diagnostic imaging space.
Mechanism of Action
Radiopharmaceutical Activity
Pharmacologic Class:
Radioactive Diagnostic Agent
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on Fludeoxyglucose F18 positions professionals in specialized nuclear medicine and regulatory domains, with limited job market activity (1 linked position). This career path emphasizes technical expertise in radiopharmaceutical handling, compliance, and health physics rather than broad commercial expansion.
Sr Health Physics Specialist
Worked on FLUDEOXYGLUCOSE F18 at Medica Corp? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.